Journal of Peking University(Health Sciences) ›› 2017, Vol. 49 ›› Issue (5): 889-892. doi: 10.3969/j.issn.1671-167X.2017.05.026

• Article • Previous Articles     Next Articles

Comparison and discussion of different surgical methods used to treat vesicovaginal fistulas

ZHANG Wei-yu, HU Hao, ZHANG Xiao-peng, SUN Yi-ran, WANG Huan-rui, XU Ke-xin   

  1. Department of Urology, Peking University People’s Hospital, Beijing 100044, China
  • Received:2017-03-15 Online:2017-10-18 Published:2017-10-18

Abstract: Objective: To compare the feasibility and prognosis of different surgical methods used for vesicovaginal fistulas and to explore the value of electrocoagulation treating small ones. Methods: The medical data of 19 patients who had undertaken transvaginal VVF repairs in Peking University People’s Hospital between October 2008 and November 2016 were retrospectively collected. The follow-ups were performed.The patients’ age ranged from 31 to 55 years with the median age of 48 years and the history length ranged from 1 month to 24 months with the median length of 3 months. Their fistula situation, surgical methods and prognosis were analyzed and the differences and similarities were compared. Results: Three patients (15.79%) was performed by electrocoagulation, 4 (21.05%) by transvaginal repair, 5 (21.32%) by laparoscopic repair and 7(36.84%) by open operation. Except one patient who rejected urinary catheter and D-J catheters, the rest of the patients discharged with catheters. Twelve patients (63.2%) got full satisfaction with one operation. One of the 3 patients who undertook electrocoagulation repeated the operation for twice and got completely cured within 1 month while the other two undertook the operation once and got dry within 1 month. Three patients who undertook transvaginal repair got dry within 1 month. Two of the 5 patients who undertook laparoscopic repair had readmission for a second operation and the other 3 got dry after operation. Five of the 7 open repair patients got dry while the other 2 attempted other center for treatment. Conclusion: Transvaginal repair has been the main surgery procedure for VVF, but it is limited by the location of fistula and the condition of vaginal. For patients not suitable for transvaginal repair, laparoscopic repair and open surgery are feasible. However both laparoscopic repair and open surgery are more invasive. Based on that, electrocoagulation becomes a better choice. In our research, patients with small and high location fistula treated by electrocoagulation got a higher cure rate and bear less surgical trauma. Electrocoagulation used in the treatment of VVF showed advantages of less trauma, less bleeding and better satisfaction. Fistulas with low location were more suitable for transvaginal repair. Complex VVF, especially with narrow ureteral open and ureteral fistulas, were more suitable for open and laparoscopic repair. As for single and small fistula, the electrocoagulation can be the first choice.

Key words: Vesicovaginal fistula, Therapy, Repair, Surgical method, Electrocoagulation

CLC Number: 

  • R694+.13
[1] 徐月敏, 撒应龙, 傅强, 等. 女性下尿路阴道瘘治疗术式的选择[J]. 中华泌尿外科杂志, 2013, 34(10): 760-766.
[2] Bora GS, Singh S, Mavuduru RS, et al. Robot-assisted vesicova-ginal fistula repair: a safe and feasible technique [J]. Int Urogynecol J, 2017, 28(6): 957-962.
[3] Agrawal V, Kucherov V, Bendana E, et al. Robot-assisted laparoscopic repair of vesicovaginal fistula: a single-center experience [J]. Urology, 2015, 86(2): 276-281.
[4] Theofanides MC, Sui W, Sebesta EM, et al. Vesicovaginal fistulas in the developed world: an analysis of disease characteristics, treatments, and complications of surgical repair using the ACS-NSQIP database [J/OL]. Neurourol Urodyn (2016-10-19)[2017-03-01]. http://onlinelibrary.wiley.com/doi/10.1002/nau.23167/abstract;jsessionid=1F80016E5AEAF50B7EDD143-39B62BED5.f04t01.
[5] Ghosh B, Wats V, Pal DK. Comparative analysis of outcome between laparoscopic versus open surgical repair for vesico-vaginal fistula [J]. Obstet Gynecol Sci, 2016, 59(6): 525-529.
[6] Bodner-Adler B, Hanzal E, Pablik E, et al. Management of vesicovaginal fistulas (VVFs) in women following benign gynaecologic surgery: A systematic review and meta-analysis [J]. PLoS One, 2017, 12(2): e0171554.
[7] Stovsky MD, Ignatoff JM, Blum MD, et al. Use of electrocoagulation in the treatment of vesicovaginal fistulas [J]. J Urol, 1994, 152(5 Pt 1): 1443-1444.
[8] Mary G, Neil H. Vesicovaginal fistulae [J]. Indian J Urol, 2010, 26(2): 253-256.
[9] Singh R, Schmitt JJ, Knoedler JJ, et al. Management of a vesicovaginal fistula using holmium laser ablation [J]. Int Urogynecol J, 2016, 27(6): 969-971.
[10] Dogra PN, Saini AK. Laser welding of vesicovaginal fistula: outcome analysis and long-term outcome: single-centre experience [J]. Int Urogynecol J, 2011, 22(8): 981-984.
[1] Qingwei MENG, Meng FAN, Huangda GUO, Hanyu ZHANG, Mengying WANG, Siyue WANG, Hexiang PENG, Xueheng WANG, Tianjiao HOU, Xueying QIN, Dafang CHEN, Jing LI, Yiqun WU, Tao WU, Hongbo CHEN, Yonghua HU. Prognostic analysis of anticoagulation therapy in elderly patients with cardioembolic stroke [J]. Journal of Peking University (Health Sciences), 2026, 58(3): 536-542.
[2] Jiale GAO, Zhongtao ZHANG. Current status and future perspectives of precision treatment for locally advanced rectal cancer [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 247-250.
[3] Hai WANG, Yizhou JIANG. Molecular mechanisms and clinical applications of anti-angiogenic therapy in precision treatment of breast cancer [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 251-256.
[4] Hao FU, Luyan SHEN, Bingyang HUANG, Shaohua MA. Clinical strategies for perioperative management of esophageal squamous cell carcinoma in the immunotherapy era [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 266-271.
[5] Weihao LI, Xuemin ZHANG, Wei LI, Tao ZHANG, Xiaoming ZHANG. Outcomes of suture-mediated vascular closure device in the closure of left brachial artery access site after thoracic endovascular aortic repair [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 388-392.
[6] Jialin LI, Liqiao CHEN, Jiatian TANG, Yan WU, Anqiang WANG. Conversion therapy for hepatoid adenocarcinoma of the stomach: A case report [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 399-404.
[7] Zichen PAN, Kai CHEN, Yukun HOU, Bohan YANG, Jixin ZHANG, Yongsu MA, Xiaodong TIAN, Yinmo YANG. Research progress in clinical pathology and molecular mechanisms of pancreatic adenosquamous carcinoma [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 431-435.
[8] Zhemin LI, Jiafu JI, Guoxin LI, Ziyu LI, Zhaode BU, Xiangyu GAO, Di DONG, Lei TANG, Xiaofang XING, Shuqin JIA, Ting GUO, Lianhai ZHANG, Fei SHAN, Xin JI, Anqiang WANG. Development and dissemination of precision medicine approaches in gastric cancer management [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 864-867.
[9] Yuanjie NIU, Zhongcheng XIN, Guiting LIN, Pan DING, Jiancheng PAN, Yuhong FENG, Yinglu GUO. Low-level laser therapy for the treatment of male infertility and erectile dysfunction [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 627-632.
[10] Wanwei HUANG, Xianshen SHA, Yibao ZHANG, Guohao WU, Feng LUO, Zhihui CHEN, Dongming YE, Xuesong LI, Caiyong LAI. Total 3D laparoscopic ileal ureters replacement for bilateral ureters combined with bladder augmentation in the management of post-radiotherapy bilateral ureteral strictures and contracted bladder [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 789-795.
[11] Qiushi XU, Tong LIU, Junjie WANG. Ferroptosis-related long non-coding RNA to predict the clinical outcome of non-small cell lung cancer after radiotherapy [J]. Journal of Peking University (Health Sciences), 2025, 57(3): 569-577.
[12] Xuejun LIANG, Fengxia ZHANG, Ting JIN, Jingjing ZHU. Biological activity and antitumor effect of long-acting recombinant human interleukin-2 drug [J]. Journal of Peking University (Health Sciences), 2025, 57(2): 253-261.
[13] Miaoyu LIU, Siyuan WANG, Lin PEI, Shu WANG. Impact of concurrent use of goserelin on the efficacy of neoadjuvant chemotherapy in young breast cancer patients [J]. Journal of Peking University (Health Sciences), 2025, 57(2): 291-297.
[14] Guangyan YU, Xin PENG, Min GAO, Peng YE, Na GE, Mengqi JIA, Bingyu LI, Zunan TANG, Leihao HU, Wenbo ZHANG. Research progress in diagnosis and treatment of salivary gland tumors [J]. Journal of Peking University (Health Sciences), 2025, 57(1): 1-6.
[15] Ying HAN, Pu ZHAO, Hongwei LIU. Microneedle combined with photodynamic therapy in the treatment of oral leukoplakia [J]. Journal of Peking University (Health Sciences), 2025, 57(1): 91-96.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!